Clearbridge Health to acquire 65% stake in medical centre in Manila

Clearbridge Health to acquire 65% stake in medical centre in Manila

Stanislaus Jude Chan
04/01/18, 07:03 pm

SINGAPORE (Jan 4): Clearbridge Health’s wholly-owned subsidiary, Clearbridge Health (Philippines), has entered into a conditional share purchase agreement to acquire 65% of the common shares in the issued share capital of Marzan Health Care Inc for 69.6 million Philippine pesos ($1.9 million).

The target company operates a medical centre offering a wide range of services including pathology services, imaging diagnostics, dental care, as well as dialysis and renal care in Manila, Philippines.

Following the completion of the proposed acquisition, Clearbridge says it also intends to enter into a subscription agreement to subscribe to cumulative, non-voting, redeemable preferred shares in Marzan at 1.00 peso per share, for a total subscription price of 25 million pesos.

Subject to approval of the Philippines Securities Exchange Commission, the proposed subscription will see Clearbridge holding 100% of the preferred shares in Marzan.

The proposed transactions will be funded via proceeds from Clearbridge’s initial public offering (IPO) and bank borrowings.

Clearbridge says the proposed transactions will provide the group with a platform to expand its business in the Philippines.

Marzan also holds the required licences to provide a wide range of medical services in the Philippines, which would allow Clearbridge to accelerate its expansion in the country.

In addition, the group says it expects to be able to leverage on Marzan’s existing distribution network to deliver the group's precision medicine products and services.

Clearbridge earlier disclosed it had entered into a term sheet for the potential acquisition in the offer document for its IPO in December.

See: Clearbridge Health to list on Catalist; seeking to raise $24.6 million

“The Philippines remains a vastly untapped market for the provision of precision medical healthcare services. We see huge potential for Clearbridge to establish a strong foothold in the precision medicine space on the back of rising affluence amongst a significant segment of the populace,” says Jeremy Yee, executive director and chief executive officer of Clearbridge.

Shares of Clearbridge closed 1.5 cents higher, or up 3.8%, at 41 cents on Thursday.

Can IBM remake itself with hybrid cloud play Red Hat?

SINGAPORE (Nov 19): Legendary corporate icons can plunge from their exalted status to irrelevance in little or no time. The unfolding saga of General Electric, the world’s largest company by market capitalisation until Microsoft overtook it at the start of the tech boom in 1999, is a case in point. GE, which has been slowly shedding assets since the global financial crisis in 2008, has seen its downward slide escalate over the past two years. Its once lofty stock has plunged 77% from its recent July 2016 peak, and is down 87% from its July 2000 all-time high when it ....

Malaysia reopens submarine probe, questions former PM Najib

KUALA LUMPUR (Nov 20): Malaysian anti-graft authorities have reopened investigations into a contentious submarine deal 16 years ago involving former prime minister Najib Razak, the latest corruption probe facing the embattled Najib. Since losing a May election, Najib has been charged with multiple criminal offences and has been subject to corruption investigations, some linked to a multi-billion dollar scandal at state fund 1Malaysia Development Berhad (1MDB). Najib has pleaded not guilty to all charges. Investigators with the Malaysian Anti Corruption Commission (MACC) are now also l....

Noble comes under investigation for potential accounting & regulatory breaches

SINGAPORE (Nov 20): Singapore authorities are launching an investigation into beleaguered commodities trader Noble Group and its wholly-owned subsidiary, Noble Resources, amid the group’s controversial debt restructuring exercise. According to a joint statement issued on Tuesday by the Singapore Police Force (SPF), Commercial Affairs Department (CAD), Monetary Authority of Singapore (MAS) and Accounting and Corporate Regulatory Authority (ACRA), Noble is suspected of making “false and misleading statements” as well as breaches of disclosure requirements under the Securities and Future....